-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Are We Ready for Innovative Decentralized Clinical Trials in Hematology? Learnings from the COVID19 Pandemic

Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Trial Designs for Decentralized Clinical Trials
Friday, December 6, 2024, 2:05 PM-2:52 PM

Jean M. M Connors, MD

Harvard Medical School, Brigham and Women's Hospital, Boston, MA

Disclosures: Connors: Abbott: Honoraria; Anthos: Honoraria; Bristol Myers Sqibb: Honoraria; Bayer: Honoraria; Janssen: Honoraria; Pfizer: Honoraria; Sanofi: Honoraria; Werfen: Honoraria; Perosphere: Honoraria.